How a new long-acting HIV drug combo tackles resistance
A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is resistant to some commonly used HIV drugs, according to a new UC San Francisco study.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Study shows how the toxic substances mixed into fentanyl vary across the US and change over time
United Kingdom
-
Personality data reveal link between neuroticism and lasting pandemic anxiety and depression
United Kingdom
-
Common herbal sleep aid shows signs of addictive potential
United Kingdom
-
Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival
United Kingdom
-
Long-running women's health studies reveal lasting lessons for disease prevention and healthy aging
United Kingdom
-
Dads are dying after their kids are born, and no one is tracking it
United Kingdom
-
NYC Parks Extends Late Night Soccer at 5 Fields for Night Workers–And Their Reactions Are Awesome (WATCH)
United Kingdom
-
Cervical cancer trial finds similar early recovery results after robot-assisted versus open surgery
United Kingdom